Skip to main content
Top
Published in: BMC Health Services Research 1/2024

Open Access 01-12-2024 | Tuberculosis | Research

Exploring health care providers’ engagement in prevention and management of multidrug resistant Tuberculosis and its factors in Hadiya Zone health care facilities: qualitative study

Authors: Bereket Aberham Lajore, Yitagesu Habtu Aweke, Samuel Yohannes Ayanto, Menen Ayele

Published in: BMC Health Services Research | Issue 1/2024

Login to get access

Abstract

Background

Engagement of healthcare providers is one of the World Health Organization strategies devised for prevention and provision of patient centered care for multidrug resistant tuberculosis. The need for current research question rose because of the gaps in evidence on health professional’s engagement and its factors in multidrug resistant tuberculosis service delivery as per the protocol in the prevention and management of multidrug resistant tuberculosis.

Purpose

The purpose of this study was to explore the level of health care providers’ engagement in multidrug resistant tuberculosis prevention and management and influencing factors in Hadiya Zone health facilities, Southern Ethiopia.

Methods

Descriptive phenomenological qualitative study design was employed between 02 May and 09 May, 2019. We conducted a key informant interview and focus group discussions using purposely selected healthcare experts working as directly observed treatment short course providers in multidrug resistant tuberculosis treatment initiation centers, program managers, and focal persons. Verbatim transcripts were translated to English and exported to open code 4.02 for line-by-line coding and categorization of meanings into same emergent themes. Thematic analysis was conducted based on predefined themes for multidrug resistant tuberculosis prevention and management and core findings under each theme were supported by domain summaries in our final interpretation of the results. To maintain the rigors, Lincoln and Guba’s parallel quality criteria of trustworthiness was used particularly, credibility, dependability, transferability, confirmability and reflexivity.

Results

Total of 26 service providers, program managers, and focal persons were participated through four focus group discussion and five key informant interviews. The study explored factors for engagement of health care providers in the prevention and management of multidrug resistant tuberculosis in five emergent themes such as patients’ causes, perceived susceptibility, seeking support, professional incompetence and poor linkage of the health care facilities. Our findings also suggest that service providers require additional training, particularly in programmatic management of drug-resistant tuberculosis.

Conclusion

The study explored five emergent themes: patient’s underlying causes, seeking support, perceived susceptibility, professionals’ incompetence and health facilities poor linkage. Community awareness creation to avoid fear of discrimination through provision of support for those with multidrug resistant tuberculosis is expected from health care providers using social behavioral change communication strategies. Furthermore, program managers need to follow the recommendations of World Health Organization for engaging healthcare professionals in the prevention and management of multidrug resistant tuberculosis and cascade trainings in clinical programmatic management of the disease for healthcare professionals.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO; Geneva, Switherland. 2014. WHO. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO; Geneva, Switherland. 2014.
2.
go back to reference WHO. Implementing the end TB Strategy: The Essentials. WHO, Geneva. Switherland; 2015. WHO. Implementing the end TB Strategy: The Essentials. WHO, Geneva. Switherland; 2015.
3.
go back to reference Eshetie S, Gizaw M, Dagnew M, Kumera G, Woldie H, Fikadu A. et.al. Multidrug-resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis Ethiopia: efforts to expand diagnostic services, treatment and care. BMC Antimicrobial Resist Infect Control. 2014;3:31. Eshetie S, Gizaw M, Dagnew M, Kumera G, Woldie H, Fikadu A. et.al. Multidrug-resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis Ethiopia: efforts to expand diagnostic services, treatment and care. BMC Antimicrobial Resist Infect Control. 2014;3:31.
4.
go back to reference Biadglegne F, Sack U, Rodloff AC. Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care. BMC Antimicro Resist Infect Control. 2014;3:31. Biadglegne F, Sack U, Rodloff AC. Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care. BMC Antimicro Resist Infect Control. 2014;3:31.
5.
go back to reference Lema NA, Majigo M, Mbelele PM, Abade AMIM. Risk factors associated with multidrug resistant tuberculosis among patients referred to Kibong’oto Infectious Disease Hospital in northern Tanzania. Tanzania J Health Res. 2016;18:4. Lema NA, Majigo M, Mbelele PM, Abade AMIM. Risk factors associated with multidrug resistant tuberculosis among patients referred to Kibong’oto Infectious Disease Hospital in northern Tanzania. Tanzania J Health Res. 2016;18:4.
6.
go back to reference Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S. G. K. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infect Dis. 2015;15:461. Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S. G. K. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infect Dis. 2015;15:461.
7.
go back to reference Selamawit H, Girmay M, Belaineh G, Muluken M, Alemayehu M, et al. PS. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health 2013. 2013;13:782. Selamawit H, Girmay M, Belaineh G, Muluken M, Alemayehu M, et al. PS. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health 2013. 2013;13:782.
8.
go back to reference Safwat TM, Elmasry AA, Mohamed A. Prevalence of multi-drug resistant tuberculosis in abbassia Chest hospital from july 2006 to december 2009. Egyptian J Bronchol. 2011;5(2):124–30. Safwat TM, Elmasry AA, Mohamed A. Prevalence of multi-drug resistant tuberculosis in abbassia Chest hospital from july 2006 to december 2009. Egyptian J Bronchol. 2011;5(2):124–30.
9.
go back to reference World Health Organization. WHO Global tuberculosis report 2015. Geneva: WHO. 2015. World Health Organization. WHO Global tuberculosis report 2015. Geneva: WHO. 2015.
10.
go back to reference Rifat M, Hall J, Oldmeadow C, Husain A, Hinderaker SG. AH. M. Factors related to previous tuberculosis treatment of patients with multidrug resistant tuberculosis in Bangladesh. BMJ Open. 2015;5. Rifat M, Hall J, Oldmeadow C, Husain A, Hinderaker SG. AH. M. Factors related to previous tuberculosis treatment of patients with multidrug resistant tuberculosis in Bangladesh. BMJ Open. 2015;5.
12.
go back to reference World Health Organization. WHO Global tuberculosis report 2018. Geneva: WHO. 2018. World Health Organization. WHO Global tuberculosis report 2018. Geneva: WHO. 2018.
13.
go back to reference Deus L, Willy S, Kenneth M, George WK, Frank JCMJ. et al. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health 2015;15. Deus L, Willy S, Kenneth M, George WK, Frank JCMJ. et al. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health 2015;15.
14.
go back to reference Federal Ministry of Health. Guidelines for Clinical and Programmatic Management of TB, TB/HIV and Leprosy in Ethiopia. Fifth Edition. Addis Ababa. March, 2013. Federal Ministry of Health. Guidelines for Clinical and Programmatic Management of TB, TB/HIV and Leprosy in Ethiopia. Fifth Edition. Addis Ababa. March, 2013.
15.
go back to reference FDRE/MOH. Guidelines on programmatic management of drug resistant tuberculosis in Ethiopia. 2ND ED.2014 ADDIS ABABA. 2014. FDRE/MOH. Guidelines on programmatic management of drug resistant tuberculosis in Ethiopia. 2ND ED.2014 ADDIS ABABA. 2014.
16.
go back to reference CSIS. Center for Strategic and International Studies. As Ethiopia moves toward tuberculosis elimination, success requires higher investment: A report of CSIS global health policy center. CSIS, Washinton DC, America. 2016. CSIS. Center for Strategic and International Studies. As Ethiopia moves toward tuberculosis elimination, success requires higher investment: A report of CSIS global health policy center. CSIS, Washinton DC, America. 2016.
17.
go back to reference World Health organization. Framework for the engagement of all health care providers in the management of drug resistant tuberculosis. Geneva; Switherland. WHO 2015. World Health organization. Framework for the engagement of all health care providers in the management of drug resistant tuberculosis. Geneva; Switherland. WHO 2015.
18.
go back to reference Vries G, Tsolova S, Anderson LF, Gebhard AC, Helda E, Hollo V. Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences. BMC Public Health. 2017;17:334. Vries G, Tsolova S, Anderson LF, Gebhard AC, Helda E, Hollo V. Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences. BMC Public Health. 2017;17:334.
19.
go back to reference Isara AR, Akpodiete A. Concerns about the knowledge and attitude of multidrug resistant tuberculosis among health care workers and patients in Delta State, Nigeria. Nigerian J Clin Pract. 2015;18:5. Isara AR, Akpodiete A. Concerns about the knowledge and attitude of multidrug resistant tuberculosis among health care workers and patients in Delta State, Nigeria. Nigerian J Clin Pract. 2015;18:5.
20.
go back to reference Luka MI, Idris SH, Patrick N, Ndadilnasiya EW, Moses OA, Phillip P., et al. Health care workers’ knowledge and attitude towards TB patients under Direct Observation of Treatment in Plateau state Nigeria, 2011. Pan Afr Med J. 2014;18 (Supp1):8. Luka MI, Idris SH, Patrick N, Ndadilnasiya EW, Moses OA, Phillip P., et al. Health care workers’ knowledge and attitude towards TB patients under Direct Observation of Treatment in Plateau state Nigeria, 2011. Pan Afr Med J. 2014;18 (Supp1):8.
21.
go back to reference Malangu N, Adebanjo OD. Knowledge and practices about multidrug-resistant tuberculosis amongst healthcare workers in Maseru. Afr J Prm Health Care Fam Med. 2015;7:1. Malangu N, Adebanjo OD. Knowledge and practices about multidrug-resistant tuberculosis amongst healthcare workers in Maseru. Afr J Prm Health Care Fam Med. 2015;7:1.
22.
go back to reference Molla Y, Jerene D, Jema I, Nigussie G, Kebede T, Kassie Y. et.al. The experience of scaling up a decentralized, ambulatory model of care for management of multidrug-resistant tuberculosis in two regions of Ethiopia. J Clinic Tubercul Other Mycobacter Dis. 2017;7:28–33. Molla Y, Jerene D, Jema I, Nigussie G, Kebede T, Kassie Y. et.al. The experience of scaling up a decentralized, ambulatory model of care for management of multidrug-resistant tuberculosis in two regions of Ethiopia. J Clinic Tubercul Other Mycobacter Dis. 2017;7:28–33.
23.
go back to reference Merza MA, Farnia P, Tabarsi P, Khazampour M, Masjedi MR. AA. V. Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB centre in Iran: a retrospective analysis. J Infect Dev Ctries. 2011;5(7):511–19. Merza MA, Farnia P, Tabarsi P, Khazampour M, Masjedi MR. AA. V. Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB centre in Iran: a retrospective analysis. J Infect Dev Ctries. 2011;5(7):511–19.
24.
go back to reference Gebremariam MK, Bjune GA. FJ. Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health. 2010;10:651. Gebremariam MK, Bjune GA. FJ. Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health. 2010;10:651.
25.
go back to reference Suri AGK. S. C. Voices from the Field: Perspectives from Community Health Workers on Health Care Delivery in Rural KwaZulu-Natal, South Africa. J Infect Dis. 2007;196:S505–11. Suri AGK. S. C. Voices from the Field: Perspectives from Community Health Workers on Health Care Delivery in Rural KwaZulu-Natal, South Africa. J Infect Dis. 2007;196:S505–11.
26.
go back to reference Deshmukh RD, Dhande DJ, Sachdeva KS, Sreenivas AN, Kumar AMV. M. P. Social support a key factor for adherence to multidrug-resistant tuberculosis treatment. Indian J Tubercul. 2017. Deshmukh RD, Dhande DJ, Sachdeva KS, Sreenivas AN, Kumar AMV. M. P. Social support a key factor for adherence to multidrug-resistant tuberculosis treatment. Indian J Tubercul. 2017.
27.
go back to reference Samuel B, Volkmann T, Cornelius S, Mukhopadhay S, Mitra K, Kumar AM., et al. Relationship between Nutritional Support and Tuberculosis Treatment Outcomes in West Bengal, India. J Tuberc Res. 2016;4(4):213–19. Samuel B, Volkmann T, Cornelius S, Mukhopadhay S, Mitra K, Kumar AM., et al. Relationship between Nutritional Support and Tuberculosis Treatment Outcomes in West Bengal, India. J Tuberc Res. 2016;4(4):213–19.
28.
go back to reference NC. E. The making of a public health problem: multi-drug resistant tuberculosis in India. Health Policy Plan 2013;28:375–85. NC. E. The making of a public health problem: multi-drug resistant tuberculosis in India. Health Policy Plan 2013;28:375–85.
30.
go back to reference Horter S, Stringer B, Greig J, Amangeldiev A, Tillashaikhov MN, Parpieva N., et al. Where there is hope: a qualitative study examining patients’ adherence to multidrug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan. BMC Infect Dis. 2016;16:362. Horter S, Stringer B, Greig J, Amangeldiev A, Tillashaikhov MN, Parpieva N., et al. Where there is hope: a qualitative study examining patients’ adherence to multidrug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan. BMC Infect Dis. 2016;16:362.
31.
go back to reference Naidoo P, Niekerk MV, Toit ED, Beyers N, Leon N. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests. BMC Health Serv Res. 2015;15:488. Naidoo P, Niekerk MV, Toit ED, Beyers N, Leon N. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests. BMC Health Serv Res. 2015;15:488.
32.
go back to reference WHO. ENGAGE-TB. Training of community health workers and community volunteers. Integrating community-based tuberculosis activities into the work of nongovernmental and other civil society organizations. 2015. WHO. ENGAGE-TB. Training of community health workers and community volunteers. Integrating community-based tuberculosis activities into the work of nongovernmental and other civil society organizations. 2015.
33.
go back to reference Gerard de Vries S, Tsolova FL, Anderson AC, Gebhard E, Heldal et al. Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences BMC Public Health. 2017;17:334. https://doi.org/10.1186/s12889-017-4216-9. Gerard de Vries S, Tsolova FL, Anderson AC, Gebhard E, Heldal et al. Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences BMC Public Health. 2017;17:334. https://​doi.​org/​10.​1186/​s12889-017-4216-9.
34.
go back to reference Finlay A, Lancaster JHT, Weyer K, Miranda A. M. W. Patient- and Provider level risk factors associated with default from tuberculosis treatment, South Africa: a case control study. BMC Publich Health. 2012;12:56. Finlay A, Lancaster JHT, Weyer K, Miranda A. M. W. Patient- and Provider level risk factors associated with default from tuberculosis treatment, South Africa: a case control study. BMC Publich Health. 2012;12:56.
Metadata
Title
Exploring health care providers’ engagement in prevention and management of multidrug resistant Tuberculosis and its factors in Hadiya Zone health care facilities: qualitative study
Authors
Bereket Aberham Lajore
Yitagesu Habtu Aweke
Samuel Yohannes Ayanto
Menen Ayele
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2024
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-024-10911-6

Other articles of this Issue 1/2024

BMC Health Services Research 1/2024 Go to the issue